These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 38826780)

  • 1. MicroRNAs and angiosarcoma: are there promising reports?
    Modarresi Chahardehi A; Afrooghe A; Emtiazi N; Rafiei S; Rezaei NJ; Dahmardeh S; Farz F; Naderi Z; Arefnezhad R; Motedayyen H
    Front Oncol; 2024; 14():1385632. PubMed ID: 38826780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
    Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
    Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
    Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
    Otmani K; Lewalle P
    Front Oncol; 2021; 11():708765. PubMed ID: 34722255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
    Sakai NS; Samia-Aly E; Barbera M; Fitzgerald RC
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):512-21. PubMed ID: 24013023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers.
    Ayed A
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6417-6437. PubMed ID: 38691151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
    Ortholan C; Puissegur MP; Ilie M; Barbry P; Mari B; Hofman P
    Curr Med Chem; 2009; 16(9):1047-61. PubMed ID: 19275611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7.
    Wang X; Song Y
    Biomed Pharmacother; 2018 Jul; 103():1061-1068. PubMed ID: 29710664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
    Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory roles and therapeutic potential of microRNA in sarcoma.
    Lim HJ; Yang JL
    Crit Rev Oncol Hematol; 2016 Jan; 97():118-30. PubMed ID: 26318097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs Improve Cancer Treatment Outcomes Through Personalized Medicine.
    Hatam S
    Microrna; 2023; 12(2):92-98. PubMed ID: 36733205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brain.
    Fassan M; Sachsenmeir K; Rugge M; Baffa R
    Front Biosci (Schol Ed); 2011 Jun; 3(3):970-9. PubMed ID: 21622246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNA in colorectal carcinoma (CRC): a narrative review.
    Sado AI; Batool W; Ahmed A; Zafar S; Patel SK; Mohan A; Zia U; Aminpoor H; Kumar V; Tejwaney U
    Ann Med Surg (Lond); 2024 Jan; 86(1):308-318. PubMed ID: 38222721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
    Kent OA; Mendell JT
    Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.